1418002-99-9

Upstream product

• 1418002-98-8 trans [4-(3-nitro-quinolin-4-ylamino)-cyclohexyl]-acetonitrile 
• 1266328-42-0 2-((1r,4r)-4-aminocyclohexyl)acetonitrile 
• 1313279-47-8 trans-(4-cyanomethyl-cyclohexyl)-carbamic acid tert-butyl ester 
• 683269-95-6 N-[trans-4-[[(methylsulfonyl)oxy]methyl]cyclohexyl]carbamic acid tert-butyl ester 
• 239074-29-4 trans (4-hydroxymethyl-cyclohexyl)-carbamic acid tert-butyl ester 

Downstream Products

• 1418002-19-3 C₂₀H₂₂N₄O 
• 1418002-21-7 C₁₉H₂₀N₄O 
• 1418003-12-9 N-tert-butylcarbamate-N-[1-(4-cyanomethyl-cyclohexyl)-1H-imidazo[4,5-c]quinolin-2-ylmethyl]-methanesulfonamide 

Relevant academic research and scientific papers

TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF AS JAK INHIBITORS

The invention provides novel compounds of formula I having the general formula:(I) wherein Rl s R2, R3, X and Y are as described herein. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment of immunological or hyperproliferative disorders.